Literature DB >> 26363224

CMKLR1 and GPR1 mediate chemerin signaling through the RhoA/ROCK pathway.

Jillian L Rourke1, Helen J Dranse1, Christopher J Sinal2.   

Abstract

Chemerin is an adipose-derived hormone that regulates immunity and energy homesotasis. To date, all known chemerin functions have been attributed to activation of the G protein-coupled receptor chemokine-like receptor-1 (CMKLR1). Chemerin is also the only known ligand for a second receptor, G protein-coupled receptor-1 (GPR1), whose signaling and function remains unknown. This study investigated the in vitro signal transduction mechanisms of CMKLR1 and GPR1 using a panel of luciferase-reporters and pathway-specific inhibitors. Herein we report the novel finding that chemerin signals through a RhoA and rho-associated protein kinase (ROCK)-dependent pathway for activation of the transcriptional regulator serum-response factor (SRF). Despite similarities in RhoA/ROCK, Gαi/o, and MAPK signaling, we also demonstrate species-specific and receptor-dependent variations in GPR1 and CMKLR1 signaling and expression of the SRF target genes EGR1, FOS and VCL. Moreover, we demonstrate that signaling through p38, Gαi/o, RhoA, and ROCK is required for chemerin-mediated chemotaxis of L1.2 lymphocytes and AGS gastric adenocarcinoma cells. These results provide, to our knowledge, the first empirical evidence that GPR1 is a functional chemerin receptor and identify RhoA/SRF as a novel chemerin-signaling axis via both CMKLR1 and GPR1.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CMKLR1; Chemerin signaling; Chemotaxis; GPR1; RhoA; SRF

Mesh:

Substances:

Year:  2015        PMID: 26363224     DOI: 10.1016/j.mce.2015.09.002

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  34 in total

1.  Chemerin-induced arterial contraction is Gi- and calcium-dependent.

Authors:  David J Ferland; Emma S Darios; Richard R Neubig; Benita Sjögren; Nguyen Truong; Rosa Torres; Thomas S Dexheimer; Janice M Thompson; Stephanie W Watts
Journal:  Vascul Pharmacol       Date:  2016-11-24       Impact factor: 5.773

2.  Interrelation of chemerin and TNF-α with mtDNA copy number in adipose tissues and blood cells in obese patients with and without type 2 diabetes.

Authors:  Daria Skuratovskaia; Pavel Zatolokin; Maria Vulf; Ilia Mazunin; Larisa Litvinova
Journal:  BMC Med Genomics       Date:  2019-03-13       Impact factor: 3.063

3.  Chemerin regulates normal angiogenesis and hypoxia-driven neovascularization.

Authors:  Cyrine Ben Dhaou; Kamel Mandi; Mickaël Frye; Angela Acheampong; Ayoub Radi; Benjamin De Becker; Mathieu Antoine; Nicolas Baeyens; Valérie Wittamer; Marc Parmentier
Journal:  Angiogenesis       Date:  2021-09-15       Impact factor: 10.658

4.  Chemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMKLR1), not G-Protein-Coupled Receptor 1 (GPR1), in Human and Rat Vasculature.

Authors:  Amanda J Kennedy; Peiran Yang; Cai Read; Rhoda E Kuc; Lucy Yang; Emily J A Taylor; Colin W Taylor; Janet J Maguire; Anthony P Davenport
Journal:  J Am Heart Assoc       Date:  2016-10-14       Impact factor: 5.501

5.  CMKLR1 activation ex vivo does not increase proportionally to serum total chemerin in obese humans.

Authors:  Jay Toulany; Sebastian D Parlee; Christopher J Sinal; Kathryn Slayter; Shelly McNeil; Kerry B Goralski
Journal:  Endocr Connect       Date:  2016-11-08       Impact factor: 3.335

6.  Identification of Three Novel Splicing Variants and Expression Analysis of Chicken GPR1 Gene.

Authors:  Xueyou Zhang; Qihai Xiao; Kai Tian; Yan Wang; Xiaoling Zhao; Huadong Yin; Diyan Li; Qing Zhu
Journal:  Biomed Res Int       Date:  2017-01-22       Impact factor: 3.411

7.  Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo.

Authors:  Conny Tümmler; Igor Snapkov; Malin Wickström; Ugo Moens; Linda Ljungblad; Lotta Helena Maria Elfman; Jan-Olof Winberg; Per Kogner; John Inge Johnsen; Baldur Sveinbjørnsson
Journal:  Oncotarget       Date:  2017-07-27

Review 8.  International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function.

Authors:  Amanda J Kennedy; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2017-12-26       Impact factor: 25.468

9.  Absence of the Non-Signalling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses In Vivo.

Authors:  Daniel Regan-Komito; Sophia Valaris; Theodore S Kapellos; Carlota Recio; Lewis Taylor; David R Greaves; Asif J Iqbal
Journal:  Front Immunol       Date:  2017-11-21       Impact factor: 7.561

10.  The role of chemerin and ChemR23 in stimulating the invasion of squamous oesophageal cancer cells.

Authors:  J Dinesh Kumar; Sandhir Kandola; Laszlo Tiszlavicz; Zita Reisz; Graham J Dockray; Andrea Varro
Journal:  Br J Cancer       Date:  2016-04-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.